[Book] Breast Cancer: Its Link to Abortion and the Birth Control Pill
1 Russo J, Tay TK, et al. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Research and Treatment. 1982; 2: 5–73. [Back]
2 Russo J, Russo IH. Susceptibility of the mammary gland to carcinogenesis. Am J Pathol. 1980; 100: 497–512. [Back]
3 Kirschstein RL, et al. Infiltrating duct carcinoma of the mammary gland of a Rhesus monkey after administration of an oral contraceptive: a preliminary report. J Natl Cancer Inst. 1972; 48: 551–553. [Back]
4 Geil, et al. FDA studies of estrogen, progestogens, and estrogen⁄progesterone combinations in the dog and monkey. J Toxicol Environ. 3:1979. [Back]
5 Shubik P. Oral contraceptives and breast cancer: laboratory evidence. In: Interpretation of Negative Epidemiological Evidence for Carcinogenicity. IARC Sci Pub. 1985: 65; 33. [Back]
6 Harlap S. Oral contraceptives and breast cancer. Cause and Effect? J Reprod Med. 374–395. [Back]
7 White E, Daling J, et al. Rising incidence of breast cancer among young women in Washington State. J Natl Cancer Inst. 1987, 79: 239–43. [Back]
8 Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiology, Biomarkers and Prevention. 1994; 3: 353–364. [Back]
9 Parker S, Tong T, et al. Cancer Statistics, 1996. American Cancer Society. 1996; 46: 1–23. [Back]
10 Henderson IC. Risk Factors for breast cancer development. Cancer (Supplement). 1993; 71: 2127–2140. [Back]
11 Kelsey J. A review of the epidemiology of human breast cancer. Epidemiologic Reuiews. 1979; 1: 74–109. [Back]
12 Henderson B, Bernstein L. The international variation in breast cancer rates: An epidemiological assessment. Breast Cancer Research and Iteatment. 1991; 18: S11–17. [Back]
13 Lanari C, Molinolo AA, et al. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in barb⁄c female mice. Cancer Letters. 1986; 33: 215–223. [Back]
14 Laarsson, KS, et al. Predictability of the safety of hormonal contraceptives from canine toxicology studies. In: Michal, F. ed. Safety Requirements for Contraceptive Steroids. Cambridge: Cambridge University Press; 1989: 203–269. [Back]
15 Skegg DCG, Noonan EA, et al. Depot medroxyprogesterone acetate and breast cancer [A pooled analysis of the World Health Organization and New Zealand studies]. JAMA. 1995: 799–804. [Back]
16 Brind J, Chinchilli M, et al. Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta–analysis. J Epidemiol Community Health. 10⁄ 1996; 50: 481–496. [Back]
17 Haskell CM. Cancer Treatment. 4th ed. Philadelphia: WB Saunders Company; 1995. [Back]
18 Romieu I, Berlin J, et al. Oral contraceptives and breast cancer. Review and meta–Analysis. Cancer. 1990; 66: 2253–2263. [Back]
19 Thomas DB. Oral contraceptives and breast cancer: review of the epidemiologic literature. Contraception. 1991; 43: 597–643. [Back]
20 Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: further results. Contraception. 1996; 34: S1–S106. [Back]
21 Pike MC, Henderson BE, et al. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer. 1981; 43: 72–76. [Back]
22 Brinton LA, Hoover R, et al. Reproductive factors in the aetiology of breast cancer. Br J Cancer. 1983; 47: 757–762. [Back]
23 Hadjimichael OC, et al. Abortion before first live birth and risk of breast cancer. Br J Cancer. 1986; 53: 281–284. [Back]
24 Rosenberg L, Palmer JR, et al. Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol. 1988; 127: 981–989. [Back]
25 Ewertz M, Duffy SW. Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer. 1988; 58: 99–104. [Back]
26 Adami HO, Bergstrom R, Lund E, Meirik O. Absence of association between reproductive variables and the risk of breast cancer in young women in Sweden and Norway. Br J Cancer 1990; 62: 122–126. [Back]
27 Daling J, Malone K, et al. Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst. 1994; 86: 1584–1592. [Back]
28 Rookus M, Leeuwen F. Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case–control study. J Natl Cancer Inst. 1996; 88: 1759–1764. [Back]
29 Brinton LA, Daling JR, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst. 6⁄7⁄1995; 87: 827–35. [Back]
30 Ewertz M. Oral contraceptives and breast cancer risk in Denmark. Eur J Cancer. 1992; 28A: 1176–1181. [Back]
31 Chilvers C, McPherson K, et al. Oral contraceptive use and breast cancer risk in young women (UK National Case–Control Study Group). The Lances. May 6, 1989: 973–982. [Back]
32 Rookus MA, Leeuwen FE. Oral contraceptives and risk of breast cancer in women ages 20–54 years. The Lances. 1994; 344: 844–851. [Back]
33 Thomas DB, Noonan EA. Breast cancer and combined oral contraceptives: results from a multinational study (The WHO collaborative study of Neoplasia and steroid contraceptives). Br J Cancer. 1990; 61: 110–119. [Back]
34 Lowe CR, MacMahon B. Breast cancer and reproductive history of women in South Wales. The Lances. Jan. 24, 1970: 153–157. [Back]
35 Mirra AP, Cole P, et al. Breast cancer in an area of high parity: Sao Paulo, Brazil. Cancer Research. 1971; 31: 77–83. [Back]
36 Helmrich S, Shapiro S, et al. Risk factors for breast cancer. Am J Epidemiol. 1983; 117: 35–45. [Back]
37 Lin TM, Chen KP, MacMahon B. Epidemiologic characteristics of cancer of the breast in Taiwan. Cancer. 1971; 27: 1497–1504. [Back]
38 Rao DN, Ganesh B, et al. Role of reproductive factors in breast cancer in a low–risk area: a case–control study. Br J Cancer. 1994, 70:129–132. [Back]
39 Soini I. Risk factors of breast cancer in Finland. Int J Epidemiol 1977; 6: 365–373. [Back]
40 La Vecchia C, et al. General epidemiology of breast cancer in northern Italy. Int J Epidemiol. 1987; 16: 347–355. [Back]
41 Yuasa S, MacMahon B. Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull World Health Org. 1970; 42: 195–204. [Back]
42 Colditz G. Epidemiology of breast cancer. Cancer. 1993; 71: 1480–1489. [Back]
43 Newcomb PA, et al. Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med. 1994; 330: 81–87. [Back]
44 McTiernan A, Thomas DB. Evidence for a protective effect of lactation on risk of breast cancer in young women. Am J Epidemiol. 1986 124: 353–358. [Back]
45 Byers T, Graham S, et al. Lactation and breast cancer. Am J Epidemiol. 1985; 121: 664–674. [Back]
46 Mayberry RM, Stoddard–Wright C. Breast cancer risk factors among black women and white women: similarities and differences. Am J Epidemiol. 1992; 136: 1445–1456. [Back]
47 Van der Kooy K, Rookus MA, et al. P53 protein overexpression in relation to risk factors for breast cancer. Am J Epidemiol. 1996 144: 924–933. [Back]
48 Yang CP, Daling JR, et al. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes and Control. 1992; 3: 475–479. [Back]
49 Colditz G, Hankinson S, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995; 332: 1589–93. [Back]
50 Beral V, et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. The Lances. 1999; 350; 1043–1047. [Back]
51 Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta–analysis and review. Cancer Causes and Control. 1994; 5: 73–82. [Back]
52 Longnecker M, Newcomb PA, et al. Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst. 1995; 87: 923–929. [Back]
53 Rothman K, et al. Teratogenicity of high vitamin A intake. N Engl J Med. 1995; 333: 1369–1373. [Back]
54 Tretli S, et al. The effects of premorbid height and weight on survival of breast cancer patients. Br J Cancer. 1990; 62: 299–303. [Back]
55 Horn–Ross PL. Multiple primary cancers involving the breast. Epidemiological Reuiews. 1993; 15: 169–176. [Back]
56 Feldman G. Is genetic testing right for you? SeIf. October,1996; 187–190. [Back]
57 Greene MH. Genetics of Breast Cancer. Mayo Clinic Proceedings. Jan. 1997; 72: 54–64. [Back]
58 McGregor DH, et al. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki 1950–1969. JNatl Cancer Inst. 1977; 59; 799–811. [Back]
59 Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976; 37: 2486–2492. [Back]
60 Malone K. Diethylstilbestrol (DES) and breast cancer. Epidemiologic Reuiews. 1993; 15: 108–109. [Back]
61 Colton T, Greenberg ER, et al. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. JAMA, 1993; 269: 2096–3000. [Back]
62 Hsieh C, et al. Twin membership and breast cancer risk. Am J Epidemiol. 1992: 136: 1321–1326. [Back]
63 Gomes L, Guimaraes M, et al. A case–control study of risk factors for breast cancer in Brazil, 1978–1987. Int J Epidemiol. 1995; 24: 292–299. [Back]
64 Jick SS, Walker AM, et al. Oral contraceptives and breast cancer. Br J Cancer. 1989; 59: 618–621. [Back]
65 Maybery RM. Age–specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Ann Epidemiol. 1994; 4: 205–213. [Back]
66 Paul C, Skegg DC, et al. Oral contraceptives and breast cancer: a national study. Br Med J. 1986; 293: 723–726. [Back]
67 White E, Malone K, Weiss N, Daling J. Breast cancer among young U.S. women in relation to oral contraceptive use. J Natl Cancer Inst. 1994; 86: 505–514. [Back]
68 Daling J, Brinton L, et al. Risk of breast cancer among white women following induced abortion. Am J Epidemiol. 1996; 144: 373–380. [Back]
Next page: Return to Page 1: